Seiichiro Yoshizawa

1.1k total citations · 1 hit paper
30 papers, 885 citations indexed

About

Seiichiro Yoshizawa is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Seiichiro Yoshizawa has authored 30 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 10 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Seiichiro Yoshizawa's work include Chronic Lymphocytic Leukemia Research (6 papers), MicroRNA in disease regulation (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Seiichiro Yoshizawa is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), MicroRNA in disease regulation (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Seiichiro Yoshizawa collaborates with scholars based in Japan. Seiichiro Yoshizawa's co-authors include Kazuma Ohyashiki, Junko H. Ohyashiki, Tomohiro Umezu, Kenko Azuma, Hiroko Tadokoro, Satoshi Imanishi, Chiaki Kobayashi, Yoshikazu Ito, Moritaka Gotoh and Daigo Akahane and has published in prestigious journals such as Blood, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Seiichiro Yoshizawa

25 papers receiving 880 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1

2014 508 citations Tomohiro Umezu, Kenko Azuma et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seiichiro Yoshizawa Japan	9	716	554	223	97	86	30	885
Hiroko Tadokoro Japan	6	774 1.1×	620 1.1×	101 0.5×	61 0.6×	93 1.1×	6	887
Bijender Kumar United States	11	464 0.6×	226 0.4×	268 1.2×	94 1.0×	164 1.9×	32	748
Wengang Chen United States	9	388 0.5×	171 0.3×	75 0.3×	125 1.3×	61 0.7×	13	647
Marta Fernández‐Mercado Spain	14	508 0.7×	356 0.6×	233 1.0×	57 0.6×	49 0.6×	24	746
Leonidas Benetatos Greece	18	932 1.3×	677 1.2×	197 0.9×	105 1.1×	45 0.5×	31	1.2k
Ji Xu China	15	325 0.5×	214 0.4×	129 0.6×	178 1.8×	169 2.0×	50	641
Dong‐ming Yao China	20	786 1.1×	315 0.6×	684 3.1×	56 0.6×	46 0.5×	61	1.0k
Andrei Cucuianu Romania	11	284 0.4×	174 0.3×	114 0.5×	82 0.8×	44 0.5×	32	509
Tong Sun United States	9	367 0.5×	275 0.5×	195 0.9×	109 1.1×	58 0.7×	22	704

Countries citing papers authored by Seiichiro Yoshizawa

Since Specialization

Citations

This map shows the geographic impact of Seiichiro Yoshizawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiichiro Yoshizawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiichiro Yoshizawa more than expected).

Fields of papers citing papers by Seiichiro Yoshizawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiichiro Yoshizawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiichiro Yoshizawa. The network helps show where Seiichiro Yoshizawa may publish in the future.

Co-authorship network of co-authors of Seiichiro Yoshizawa

This figure shows the co-authorship network connecting the top 25 collaborators of Seiichiro Yoshizawa. A scholar is included among the top collaborators of Seiichiro Yoshizawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiichiro Yoshizawa. Seiichiro Yoshizawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamada, Akiko, Yoichi Araki, Yuko Tanaka, et al.. (2021). Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study. PLoS ONE. 16(7). e0253025–e0253025. 1 indexed citations

Yamada, Akiko, Seiichiro Katagiri, Seiichiro Yoshizawa, et al.. (2021). Epstein-Barr virus-associated post-transplant lymphoproliferative disease during dasatinib treatment occurred 10 years after umbilical cord blood transplantation. Journal of Infection and Chemotherapy. 27(7). 1076–1079. 3 indexed citations

Katagiri, Seiichiro, Daigo Akahane, Akiko Yamada, et al.. (2021). Elevation of HHV-6 viral load mimicking HHV-6 reactivation after second umbilical cord blood transplantation in chromosomally integrated human herpesvirus-6. Journal of Infection and Chemotherapy. 27(10). 1517–1519. 2 indexed citations

Umezu, Tomohiro, Satoshi Imanishi, Seiichiro Yoshizawa, et al.. (2020). Downregulation of extracellular vesicle microRNA‑101 derived from bone marrow mesenchymal stromal cells in myelodysplastic syndrome with disease progression. Oncology Letters. 19(3). 2053–2061. 6 indexed citations

Akahane, Daigo, Seiichiro Katagiri, Seiichiro Yoshizawa, et al.. (2020). Successful cord blood transplantation for myelodysplastic syndrome complicated by Mycobacterium kansasii pneumonia. Transplant Infectious Disease. 23(4). e13463–e13463.

Gotoh, Moritaka, Seiichiro Yoshizawa, Daigo Akahane, et al.. (2019). [Human herpesvirus-6 pneumonitis following autologous peripheral blood stem cell transplantation].. PubMed. 59(3). 300–304.

Yoshizawa, Seiichiro, Tomohiro Umezu, Moritaka Gotoh, et al.. (2018). Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation. International Journal of Molecular Sciences. 19(9). 2493–2493. 19 indexed citations

Ito, Yoshikazu, Tomohiro Umezu, Seiichiro Katagiri, et al.. (2018). BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma. Leukemia & lymphoma. 60(5). 1283–1288. 4 indexed citations

Tanaka, Yuko, et al.. (2017). Unique radiological features of two cases of primary pulmonary diffuse large B-cell lymphoma. Thorax. 72(9). 859–860. 3 indexed citations

10.

Azuma, Kenko, Tomohiro Umezu, Satoshi Imanishi, et al.. (2017). Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing. Leukemia Research. 62. 23–28. 10 indexed citations

11.

Katagiri, Seiichiro, Tetsuzo Tauchi, Tomohiro Umezu, et al.. (2015). [Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib].. PubMed. 56(2). 216–9.

12.

Gotoh, Moritaka, Seiichiro Yoshizawa, Seiichiro Katagiri, et al.. (2014). Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2–4 acute graft‐versus‐host disease. Transplant Infectious Disease. 16(3). 440–449. 22 indexed citations

13.

Gotoh, Moritaka, Seiichiro Yoshizawa, Seiichiro Katagiri, et al.. (2014). A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies. Bone Marrow Transplantation. 49(7). 955–960. 2 indexed citations

14.

Katagiri, Seiichiro, Seiichiro Yoshizawa, Moritaka Gotoh, Itaru Nakamura, & Kazuma Ohyashiki. (2014). Disseminated <i>Mycobacterium Abscessus</i> Infection with Hemophagocytic Syndrome during Treatment of Chronic Lymphocytic Leukemia. Nihon Naika Gakkai Zasshi. 103(3). 734–737. 4 indexed citations

15.

Yoshizawa, Seiichiro, Tomohiro Umezu, Junko H. Ohyashiki, Shinsuke Iida, & Kazuma Ohyashiki. (2013). Lower Plasma Mir-92a Levels Predict Shorter Progression-Free Survival In Newly Diagnosed Symptomatic Multiple Myeloma Patients. Blood. 122(21). 1879–1879. 1 indexed citations

16.

Ohyashiki, Kazuma, Tomohiro Umezu, Seiichiro Yoshizawa, et al.. (2011). Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma. PLoS ONE. 6(2). e16408–e16408. 81 indexed citations

17.

Yoshizawa, Seiichiro, Junko H. Ohyashiki, Tomohiro Umezu, et al.. (2011). Plasma Mir-92a Levels in Multiple Myeloma Correlate with T-Cell-Derived Mir-92a and Restored in Bortezomib Responder. Blood. 118(21). 2871–2871. 1 indexed citations

18.

Gotoh, Moritaka, Tetsuzo Tauchi, Seiichiro Yoshizawa, et al.. (2010). Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR–ABL mutation. International Journal of Hematology. 91(1). 128–131. 3 indexed citations

19.

Yoshizawa, Seiichiro, Yu Zhang, Daigo Akahane, et al.. (2010). Determination of donor-derived killer immunoglobulin-like receptor (KIR) by sequential genotyping in hematopoietic stem cell-transplanted patients. Hematology. 15(6). 397–405. 1 indexed citations

20.

Kiguchi, Toru, Yuta Yoshino, Bo Yuan, et al.. (2009). Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia. Leukemia Research. 34(3). 403–405. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact